Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (131-140 of 288) with videos related to

Pageof 29
Sort By:
Journal of Clinical Microbiology|October 9, 2003
Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assaysFrancesco Broccolo, Paolo Scarpellini, Giuseppe Locatelli, et al.
Journal of Neurovirology|April 24, 2003
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literaturePaola Cinque, Simona Bossolasco, Anna Maria Brambilla, et al.
AIDS (London, England)|February 3, 2021
Exercise ECG for coronary artery disease screening in people living with HIVCamilla Muccini, Laura Galli, Andrea Poli, et al.
Journal of Clinical Microbiology|November 8, 2003
Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasisSimona Bossolasco, Giovanni Gaiera, Davide Olchini, et al.
The New Microbiologica|August 22, 2017
Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: an Italian pilot study in a dental clinicMaria Rita Parisi, Simona Tecco, Giorgio Gastaldi, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2010
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravirFilippo Canducci, Maria Chiara Marinozzi, Michela Sampaolo, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosisMarco Merli, Laura Galli, Letizia Marinaro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51)Sharon L Walmsley, Christine Katlama, Adriano Lazzarin, et al.
HIV Clinical Trials|March 18, 2015
The maraviroc expanded access program - safety and efficacy data from an open-label studyAdriano Lazzarin, Jacques Reynes, Jean-Michel Molina, et al.
Journal of Neuroimmunology|December 8, 2004
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system diseaseNicolai Sidenius, Manuela Nebuloni, Stefania Sala, et al.
Pageof 29

Showing results (131-140 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Microbiology|October 9, 2003
Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assaysFrancesco Broccolo, Paolo Scarpellini, Giuseppe Locatelli, et al.
Journal of Neurovirology|April 24, 2003
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literaturePaola Cinque, Simona Bossolasco, Anna Maria Brambilla, et al.
AIDS (London, England)|February 3, 2021
Exercise ECG for coronary artery disease screening in people living with HIVCamilla Muccini, Laura Galli, Andrea Poli, et al.
Journal of Clinical Microbiology|November 8, 2003
Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasisSimona Bossolasco, Giovanni Gaiera, Davide Olchini, et al.
The New Microbiologica|August 22, 2017
Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: an Italian pilot study in a dental clinicMaria Rita Parisi, Simona Tecco, Giorgio Gastaldi, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2010
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravirFilippo Canducci, Maria Chiara Marinozzi, Michela Sampaolo, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosisMarco Merli, Laura Galli, Letizia Marinaro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51)Sharon L Walmsley, Christine Katlama, Adriano Lazzarin, et al.
HIV Clinical Trials|March 18, 2015
The maraviroc expanded access program - safety and efficacy data from an open-label studyAdriano Lazzarin, Jacques Reynes, Jean-Michel Molina, et al.
Journal of Neuroimmunology|December 8, 2004
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system diseaseNicolai Sidenius, Manuela Nebuloni, Stefania Sala, et al.
Pageof 29